Crown Bioscience
Crown Bioscience is a contract research & translational technology company making precision medicine a reality
News releases
-
Crown Bioscience Achieves Green Lab Sustainability Certification
Crown Bioscience achieves 'Green' My Green Lab Certification in the Netherlands, highlighting leadership in sustainable lab best practices worldwide.
-
Crown Bioscience and NEXT Oncology Cement Partnership Extension
Crown Bioscience and NEXT Oncology renew collaboration, combining global clinical trial expertise and innovative cancer models for oncology drug development.
-
AACR 2025: Crown Bioscience Unveils 3D Bone Marrow Niche In Vitro Models for Oncology Preclinical Screening in Hemato...
Crown Bioscience launches 3D bone marrow niche in vitro models at AACR 2025, advancing predictive oncology screening for hematological malignancies.
-
Crown Bioscience Appoints John Gu as Chief Executive Officer
Crown Bioscience appoints John Gu as CEO, leveraging his expertise in AI-driven drug discovery to advance biotechnological innovation and global health.
-
Crown Bioscience Completes Merger with Indivumed Services
Crown Bioscience completes Indivumed Services merger, offering enhanced drug development solutions globally and retiring the Indivumed brand.
-
Crown Bioscience Germany GmbH Achieves Continued CAP 15189:2022 Accreditation
Crown Bioscience's Hamburg site secures continued CAP ISO 15189:2022 accreditation, showcasing its commitment to quality in laboratory services.